Overexpression of Bcl2 in tumor-specific T cells promoted cell survival and therapeutic efficacy of adoptively transferred T cells infiltrating mouse melanomas (Charo et al., 2005; Kalbasi et al., 2010). Here, BCL2 is linked to neoplasm.